雌激素受体α-PvuII多态性对特发性男性不育的保护作用:病例对照研究与Meta分析
该病例对照研究纳入226例不育男性和213例生育男性,采用PCR-RFLP法检测ERα-PvuII基因型,并汇总7项研究进行Meta分析。结果发现ERα-PvuII在纯合子模型中与男性不育风险降低相关(OR=0.54,95%CI=0.3-0.98,p=0.042),Meta分析显示杂合子共显性模型中亦与风险降低相关(OR=0.80,95%CI=0.64-0.99,p=0.042)。作者认为ERα-PvuII多态性可能是男性不育的保护因素。
要点
- 病例对照研究显示ERα-PvuII纯合子模型与男性不育风险降低相关(OR=0.54,95%CI=0.3-0.98,p=0.042)。
- Meta分析显示ER-PvuII杂合子共显性模型与男性不育风险降低相关(OR=0.80,95%CI=0.64-0.99,p=0.042)。
- 生物信息学分析提示ER-PvuII多态性可显著影响ERα的RNA结构(p=0.004)。
核心结论
- 作者认为ERα-PvuII多态性可能是男性不育的保护因素。
研究设计与样本
- 病例对照研究纳入226例不育男性和213例生育男性,采用PCR-RFLP法进行ERα-PvuII基因分型。
- Meta分析汇总通过PubMed、Embase、Google Scholar和Science Direct数据库检索到的另外7项符合条件的研究数据。
- 采用固定效应或随机效应模型估计汇总比值比,并用生物信息学工具评估ERα-PvuII多态性的分子效应。
主要发现
- 病例对照研究中,ERα-PvuII在纯合子模型中与男性不育风险降低显著相关(OR=0.54,95%CI=0.3-0.98,p=0.042)。
- 弱精子症亚组中观察到类似关联(OR=0.4,95%CI=0.18-0.9,p=0.025)。
- Meta分析显示ER-PvuII多态性在杂合子共显性模型中与男性不育风险降低显著相关(OR=0.80,95%CI=0.64-0.99,p=0.042)。
- 分层分析中,高加索人亚组在显性遗传模型(OR=0.66,95%CI=0.45-0.96,p=0.029)和杂合子共显性模型(OR=0.62,95%CI=0.41-0.93,p=0.021)中均显示保护性关联。
- 样本量小于400例的研究在杂合子共显性模型中亦显示显著关联(OR=0.69,95%CI=0.50-0.95,p=0.023)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is there any genetic association between oestrogen receptor alpha [ERα]-PvuII polymorphism and idiopathic male infertility? DESIGN: A total of 226 infertile and 213 fertile men participated in the present case-control study. ERα-PvuII genotyping was performed using the polymerase chain reaction-restriction fragment length polymorphism [PCR-RFLP] method. Meta-analysis was also performed by pooling data collected from seven other eligible studies identified by searches of PubMed, Embase, Google Scholar, and Science Direct databases. Summary odds ratios were estimated by fixed- or random-effects models. The molecular effects of ERα-PvuII polymorphism were evaluated by bioinformatics tools. RESULTS: A significant protective association was reported between ERα-PvuII and male infertility in the homozygote model [OR=0.54, 95%CI=0.3-0.98, p=0.042]. Also, a similar association was observed in asthenozoospermia subgroup [OR=0.4, 95%CI=0.18-0.9, p=0.025]. Meta-analysis also revealed that the ER-PvuII polymorphism was significantly associated with the decreased risk of male infertility in the heterozygote co-dominant model [OR=0.80, 95%CI=0.64-0.99, p=0.042]. Moreover, similar protective results were reported in stratified analyses in Caucasian subgroup in the dominant genetic model [OR=0.66, 95%CI=0.45-0.96, p=0.029] and in the heterozygote co-dominant model [OR=0.62, 95%CI=0.41-0.93, p=0.021]. A significant association was also found in studies with sample size of less than 400 subjects in heterozygote co-dominant model [OR=0.69, 95%CI=0.50-0.95, p=0.023]. The bioinformatics data indicated that ER-PvuII polymorphism could significantly affect RNA structure of ERα [p=0.004]. CONCLUSION: The ERα-PvuII polymorphism could be considered as a possible protective factor against male infertility.
引用
- Mobasseri N, Nikzad H, Karimian M, et al. Protective effect of oestrogen receptor α-PvuII transition against idiopathic male infertility: a case-control study and meta-analysis. Reprod Biomed Online. 2019. PMID: 30738766. doi:10.1016/j.rbmo.2019.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。